← Leaderboards
Richard Conrad Straube
Soligenix, Inc.
$3,189,817
Attributed
$3,189,817
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2014–18$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,189,817 · 3
By mechanism
R44$2,964,817 · 2
R43$225,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Radiation”
- Philip J Disaia · University Of California Irvine$135,204,929
- Walter John Curran · Thomas Jefferson University$132,574,833
- Richard L Schilsky · University Of Chicago$122,521,723
- Polly Chang · Sri International$120,948,376
- Maury Tigner · Cornell University$104,613,212
- Norman Wolmark · Nsabp Foundation, Inc.$104,551,329
Research focus
RadiationMalignant NeoplasmsPlacebosAdverse EffectsFundingClinical ResearchPharmaceutical PreparationsDesignQuality Of LifeDouble-Blind MethodRequest For ProposalsSafetyTumorUlcerLesionUnited StatesResponsePhysiciansPharmacologic SubstanceMortalityNovel TherapeuticsMarketingHead And Neck CancerGastrointestinal Tract Structure
Grant awards (5)
SGX942 to Decrease Oral Mucositis After Chemoradiation for Head and Neck Cancer$750,000
R44 · FY2018 · DE · contact PI
Phase 3 Study of SGX301 and Fluorescent Light for Cutaneous T Cell Lymphoma$750,000
R44 · FY2018 · CA · contact PI
Phase 3 Study of SGX301 and Fluorescent Light for Cutaneous T Cell Lymphoma$750,000
R44 · FY2017 · CA · contact PI
SGX942 to Decrease Oral Mucositis After Chemoradiation for Head and Neck Cancer$714,817
R44 · FY2017 · DE · contact PI
SGX942 to Decrease Oral Mucositis After Chemoradiation for Head and Neck Cancer$225,000
R43 · FY2014 · DE · contact PI